D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 104 Citations 37,459 375 World Ranking 3102 National Ranking 123

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Internal medicine

David Capper spends much of his time researching Pathology, Cancer research, Immunohistochemistry, Astrocytoma and Internal medicine. His Pathology study frequently involves adjacent topics like DNA methylation. His DNA methylation research is multidisciplinary, incorporating perspectives in Methylation, Central nervous system, Genome and Histopathology.

The study incorporates disciplines such as Mutation, V600E, Mutant protein, ATRX and Cell type in addition to Cancer research. His Immunohistochemistry study combines topics from a wide range of disciplines, such as Biomarker, Antibody, Melanoma and Mutant. His studies deal with areas such as IDH2 and IDH1 as well as Astrocytoma.

His most cited work include:

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. (858 citations)
  • A complex secretory program orchestrated by the inflammasome controls paracrine senescence (841 citations)
  • DNA methylation-based classification of central nervous system tumours (733 citations)

What are the main themes of his work throughout his whole career to date?

David Capper mostly deals with Pathology, Cancer research, DNA methylation, Immunohistochemistry and Internal medicine. His study explores the link between Pathology and topics such as Glioma that cross with problems in IDH1. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, V600E and Antibody.

His research integrates issues of Copy number analysis, Methylation and Epigenetics in his study of DNA methylation. His research in Immunohistochemistry intersects with topics in Carcinoma and Mutant. His research investigates the link between Internal medicine and topics such as Oncology that cross with problems in Bioinformatics, Temozolomide, Survival rate, Cohort and Medulloblastoma.

He most often published in these fields:

  • Pathology (66.97%)
  • Cancer research (62.90%)
  • DNA methylation (40.05%)

What were the highlights of his more recent work (between 2018-2021)?

  • DNA methylation (40.05%)
  • Cancer research (62.90%)
  • Pathology (66.97%)

In recent papers he was focusing on the following fields of study:

David Capper mainly focuses on DNA methylation, Cancer research, Pathology, Oncology and Internal medicine. His DNA methylation research integrates issues from Immunohistochemistry, Methylation, Epigenetics and Ependymoma. His work on Pilocytic astrocytoma as part of general Cancer research research is often related to Isocitrate dehydrogenase, thus linking different fields of science.

His specific area of interest is Pathology, where David Capper studies Cytokeratin. The various areas that he examines in his Oncology study include Methylation profiling, IDH1, Glioma, ROS1 and Cohort. His Internal medicine study combines topics in areas such as Promoter methylation and Genome.

Between 2018 and 2021, his most popular works were:

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
  • Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes (30 citations)
  • Infant high grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes (30 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

His primary areas of study are DNA methylation, Cancer research, Glioma, Internal medicine and Oncology. The DNA methylation study combines topics in areas such as Squamous-cell carcinoma of the lung, Methylation and Ependymoma, Pathology. David Capper does research in Cancer research, focusing on Pilocytic astrocytoma specifically.

As part of the same scientific family, David Capper usually focuses on Glioma, concentrating on Glioblastoma and intersecting with Mutant, CDKN2A and DNA sequencing. His Internal medicine research includes elements of Exome sequencing, Genome and Methylation profiling. His Oncology research incorporates elements of Gene, Pharmacodynamics, Galunisertib and Temozolomide.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper.
Acta Neuropathologica (2009)

1089 Citations

Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma.

Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik.
Acta Neuropathologica (2011)

1084 Citations

A complex secretory program orchestrated by the inflammasome controls paracrine senescence

Juan Carlos Acosta;Ana Banito;Torsten Wuestefeld;Athena Georgilis.
Nature Cell Biology (2013)

1062 Citations

DNA methylation-based classification of central nervous system tumours

David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt.
Nature (2018)

860 Citations

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: Implications for classification of gliomas

Christian Hartmann;Christian Hartmann;Bettina Hentschel;Wolfgang Wick;Wolfgang Wick;David Capper.
Acta Neuropathologica (2010)

843 Citations

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups

Kristian W. Pajtler;Kristian W. Pajtler;Hendrik Witt;Martin Sill;David T.W. Jones.
Cancer Cell (2015)

640 Citations

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors.

David Capper;Susanne Weißert;Jörg Balss;Antje Habel.
Brain Pathology (2010)

617 Citations

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper;David Capper;Matthias Preusser;Matthias Preusser;Antje Habel;Felix Sahm;Felix Sahm.
Acta Neuropathologica (2011)

529 Citations

Monoclonal antibody specific for IDH1 R132H mutation.

David Capper;Hanswalter Zentgraf;Jörg Balss;Christian Hartmann;Christian Hartmann.
Acta Neuropathologica (2009)

506 Citations

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt.
Cell (2016)

479 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David Capper

Stefan M. Pfister

Stefan M. Pfister

German Cancer Research Center

Publications: 258

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 252

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 198

Felix Sahm

Felix Sahm

University Hospital Heidelberg

Publications: 167

Michael Weller

Michael Weller

University of Zurich

Publications: 140

David T. W. Jones

David T. W. Jones

German Cancer Research Center

Publications: 111

Arie Perry

Arie Perry

University of California, San Francisco

Publications: 110

Marcel Kool

Marcel Kool

German Cancer Research Center

Publications: 104

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 91

Pieter Wesseling

Pieter Wesseling

University of Amsterdam

Publications: 88

Michael D. Taylor

Michael D. Taylor

University of Toronto

Publications: 85

Matthias Preusser

Matthias Preusser

Medical University of Vienna

Publications: 81

Guido Reifenberger

Guido Reifenberger

Heinrich Heine University Düsseldorf

Publications: 79

Keith L. Ligon

Keith L. Ligon

Harvard University

Publications: 75

Torsten Pietsch

Torsten Pietsch

University of Bonn

Publications: 70

Dominique Figarella-Branger

Dominique Figarella-Branger

Aix-Marseille University

Publications: 62

Something went wrong. Please try again later.